Table 1

Patients’ clinical and pathologic characteristics

CharacteristicAll patients (n=37)C (n=17)CR (n=20)P value
Age at surgery (years) (mean (range))62 (51–81)63 (54–81)61 (51–77)0.18
Race (n (%))
 Caucasian10 (27)4 (24)6 (30)0.66
 African-American27 (73)13 (76)14 (70)
FIGO stage (n (%))
 IIIA1 (3)0 (0)1 (5)0.12
 IIIB3 (8)1 (6)2 (10)
 IIIC112 (32)6 (35)6 (30)
 IIIC29 (25)4 (24)5 (25)
 IVA0 (0)0 (0)0 (0)
 IVB12 (32)6 (35)6 (30)
Cytoreduction status (n (%))
 Optimal34 (92)15 (88)19 (95)0.45
 Suboptimal3 (8)2 (12)1 (5)
Histology (n (%))
 Endometrioid18 (49)9 (53)9 (45)0.83
 Serous15 (40)7 (41)8 (40)
 Clear cell4 (11)1 (6)3 (15)
  • C, chemotherapy-alone; CR, chemoradiation; FIGO, International Federation of Obstetrics and Gynecology.